Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 223

1.

Safety and effectiveness of hormonal contraception for women who use opioids: A systematic review.

Ti A, Stone RH, Whiteman M, Curtis KM.

Contraception. 2019 Dec;100(6):480-483. doi: 10.1016/j.contraception.2019.08.006. Epub 2019 Sep 1.

PMID:
31484059
2.

Changes in US health care provider attitudes related to contraceptive safety before and after the release of National Guidance.

Zapata LB, Morgan IA, Curtis KM, Folger SG, Whiteman MK.

Contraception. 2019 Nov;100(5):413-419. doi: 10.1016/j.contraception.2019.07.142. Epub 2019 Jul 29.

PMID:
31369735
3.

Healthcare provider knowledge regarding oral contraception effectiveness for women with a history of bariatric malabsorptive procedures.

Shah JP, Jatlaoui TC, Zapata LB, Curtis KM, Pagano HP, Whiteman MK.

Surg Obes Relat Dis. 2019 Aug;15(8):1355-1361. doi: 10.1016/j.soard.2019.06.007. Epub 2019 Jun 17.

4.

Postpartum hormonal contraception use and incidence of postpartum depression: a systematic review.

Ti A, Curtis KM.

Eur J Contracept Reprod Health Care. 2019 Apr;24(2):109-116. doi: 10.1080/13625187.2019.1569610. Epub 2019 Mar 28.

PMID:
30920314
5.

Factors associated with postpartum use of long-acting reversible contraception.

Oduyebo T, Zapata LB, Boutot ME, Tepper NK, Curtis KM, D'Angelo DV, Marchbanks PA, Whiteman MK.

Am J Obstet Gynecol. 2019 Jul;221(1):43.e1-43.e11. doi: 10.1016/j.ajog.2019.03.005. Epub 2019 Mar 15.

PMID:
30885772
6.

In Reply.

Jatlaoui TC, Whiteman MK, Jeng G, Tepper NK, Curtis KM.

Obstet Gynecol. 2019 Mar;133(3):582-583. doi: 10.1097/AOG.0000000000003145. No abstract available.

PMID:
30801457
7.

Factors associated with provision of depot medroxyprogesterone acetate to adolescents by US health care providers.

Ermias Y, Morgan IA, Curtis KM, Whiteman MK, Horton LG, Zapata LB.

Contraception. 2019 May;99(5):300-305. doi: 10.1016/j.contraception.2019.01.005. Epub 2019 Feb 11.

PMID:
30763582
8.

Venous Thromboembolism Among Women Initiating Depot Medroxyprogesterone Acetate Immediately Postpartum.

Tepper NK, Jeng G, Curtis KM, Boutot ME, Boulet SL, Whiteman MK.

Obstet Gynecol. 2019 Mar;133(3):533-540. doi: 10.1097/AOG.0000000000003135.

PMID:
30741807
9.

Health Care Provider Attitudes about the Safety of "Quick Start" Initiation of Long-Acting Reversible Contraception for Adolescents.

Morgan IA, Zapata LB, Curtis KM, Whiteman MK.

J Pediatr Adolesc Gynecol. 2019 Aug;32(4):402-408. doi: 10.1016/j.jpag.2019.01.007. Epub 2019 Feb 4.

PMID:
30731216
10.

Health Care Provider Attitudes and Practices Related to 'Quick Start' Provision of Combined Hormonal Contraception and Depot Medroxyprogesterone Acetate to Adolescents.

Morgan IA, Ermias Y, Zapata LB, Curtis KM, Whiteman MK.

J Adolesc Health. 2019 Feb;64(2):211-218. doi: 10.1016/j.jadohealth.2018.08.012. Epub 2018 Nov 2.

PMID:
30392865
11.

Contraceptive Counseling in Clinical Settings: An Updated Systematic Review.

Zapata LB, Pazol K, Dehlendorf C, Curtis KM, Malcolm NM, Rosmarin RB, Frederiksen BN.

Am J Prev Med. 2018 Nov;55(5):677-690. doi: 10.1016/j.amepre.2018.07.006.

12.

Intrauterine Device Expulsion After Postpartum Placement: A Systematic Review and Meta-analysis.

Jatlaoui TC, Whiteman MK, Jeng G, Tepper NK, Berry-Bibee E, Jamieson DJ, Marchbanks PA, Curtis KM.

Obstet Gynecol. 2018 Oct;132(4):895-905. doi: 10.1097/AOG.0000000000002822.

13.

Dissemination and use of WHO family planning guidance and tools: a qualitative assessment.

Kraft JM, Oduyebo T, Jatlaoui TC, Curtis KM, Whiteman MK, Zapata LB, Gaffield ME.

Health Res Policy Syst. 2018 May 22;16(1):42. doi: 10.1186/s12961-018-0321-1.

14.

Hormonal Contraceptive Use Among Women of Older Reproductive Age: Considering Risks and Benefits.

Tepper NK, Godfrey EM, Folger SG, Whiteman MK, Marchbanks PA, Curtis KM.

J Womens Health (Larchmt). 2018 Apr;27(4):413-417. doi: 10.1089/jwh.2018.6985. Epub 2018 Mar 19.

PMID:
29634450
15.

Health Care Provider Perceptions of the Safety of IUDs for Women with HIV.

Simmons KB, Zapata L, Curtis KM.

Perspect Sex Reprod Health. 2018 Jun;50(2):67-73. doi: 10.1363/psrh.12056. Epub 2018 Mar 30.

PMID:
29603597
16.

A systematic review and meta-analysis of venous thrombosis risk among users of combined oral contraception.

Dragoman MV, Tepper NK, Fu R, Curtis KM, Chou R, Gaffield ME.

Int J Gynaecol Obstet. 2018 Jun;141(3):287-294. doi: 10.1002/ijgo.12455. Epub 2018 Feb 22. Review.

17.

Reply.

Tepper NK, Curtis KM, Champaloux SW.

Am J Obstet Gynecol. 2018 Mar;218(3):364-365. doi: 10.1016/j.ajog.2017.11.586. Epub 2017 Nov 23. No abstract available.

PMID:
29175249
18.

Drug interactions between rifamycin antibiotics and hormonal contraception: a systematic review.

Simmons KB, Haddad LB, Nanda K, Curtis KM.

BJOG. 2018 Jun;125(7):804-811. doi: 10.1111/1471-0528.15027. Epub 2017 Dec 15.

19.

Meeting Summary: State and Local Implementation Strategies for Increasing Access to Contraception During Zika Preparedness and Response - United States, September 2016.

Kroelinger CD, Romero L, Lathrop E, Cox S, Morgan I, Frey MT, Warner L, Curtis KM, Pazol K, Barfield WD, Meaney-Delman D, Jamieson DJ.

MMWR Morb Mortal Wkly Rep. 2017 Nov 10;66(44):1230-1235. doi: 10.15585/mmwr.mm6644a6.

20.

Update to CDC's U.S. Medical Eligibility Criteria for Contraceptive Use, 2016: Revised Recommendations for the Use of Hormonal Contraception Among Women at High Risk for HIV Infection.

Tepper NK, Krashin JW, Curtis KM, Cox S, Whiteman MK.

MMWR Morb Mortal Wkly Rep. 2017 Sep 22;66(37):990-994. doi: 10.15585/mmwr.mm6637a6.

21.

Drug interactions between non-rifamycin antibiotics and hormonal contraception: a systematic review.

Simmons KB, Haddad LB, Nanda K, Curtis KM.

Am J Obstet Gynecol. 2018 Jan;218(1):88-97.e14. doi: 10.1016/j.ajog.2017.07.003. Epub 2017 Jul 8. Review.

PMID:
28694152
22.

Contraception for women with multiple sclerosis: Guidance for healthcare providers.

Houtchens MK, Zapata LB, Curtis KM, Whiteman MK.

Mult Scler. 2017 May;23(6):757-764. doi: 10.1177/1352458517701314. Epub 2017 Mar 24. Review.

23.

Removing barriers to contraception through use of criteria to assess pregnancy risk.

Tepper NK, Curtis KM, Jatlaoui TC, Whiteman MK.

Contraception. 2017 Apr;95(4):323-325. doi: 10.1016/j.contraception.2017.02.002. Epub 2017 Feb 15. No abstract available.

PMID:
28214517
24.

Long-Acting Reversible Contraception.

Curtis KM, Peipert JF.

N Engl J Med. 2017 Feb 2;376(5):461-468. doi: 10.1056/NEJMcp1608736. Review. No abstract available.

25.

Healthcare Provider Attitudes Regarding Contraception for Women with Obesity.

Jatlaoui TC, Zapata LB, Curtis KM, Folger SG, Marchbanks PA, Mandel MG, Jamieson DJ.

J Womens Health (Larchmt). 2017 Aug;26(8):870-877. doi: 10.1089/jwh.2016.5930. Epub 2017 Jan 31.

26.

Use of combined hormonal contraceptives among women with migraines and risk of ischemic stroke.

Champaloux SW, Tepper NK, Monsour M, Curtis KM, Whiteman MK, Marchbanks PA, Jamieson DJ.

Am J Obstet Gynecol. 2017 May;216(5):489.e1-489.e7. doi: 10.1016/j.ajog.2016.12.019. Epub 2016 Dec 26.

PMID:
28034652
27.

Healthcare Provider Attitudes of Safety of Intrauterine Devices in the Postpartum Period.

Rauh-Benoit LA, Tepper NK, Zapata LB, Whiteman MK, Curtis KM, Mandel MG, Marchbanks PA, Jamieson DJ.

J Womens Health (Larchmt). 2017 Jul;26(7):768-773. doi: 10.1089/jwh.2016.5985. Epub 2016 Dec 19.

PMID:
27992305
28.

Decreased STAT3 Phosphorylation Mediates Cell Swelling in Ammonia-Treated Astrocyte Cultures.

Jayakumar AR, Curtis KM, Panickar KS, Shamaladevi N, Norenberg MD.

Biology (Basel). 2016 Dec 2;5(4). pii: E48.

29.

Updated Guidance for Safe and Effective Use of Contraception.

Tepper NK, Curtis KM, Jatlaoui TC, Whiteman MK.

J Womens Health (Larchmt). 2016 Nov;25(11):1097-1101.

PMID:
27841957
30.

Combined hormonal contraceptive (CHC) use among obese women and contraceptive effectiveness: a systematic review.

Dragoman MV, Simmons KB, Paulen ME, Curtis KM.

Contraception. 2017 Feb;95(2):117-129. doi: 10.1016/j.contraception.2016.10.010. Epub 2016 Nov 4. Review.

PMID:
27823942
31.

The safety of intrauterine devices among young women: a systematic review.

Jatlaoui TC, Riley HEM, Curtis KM.

Contraception. 2017 Jan;95(1):17-39. doi: 10.1016/j.contraception.2016.10.006. Epub 2016 Oct 19. Review.

32.

An updated systematic review of epidemiological evidence on hormonal contraceptive methods and HIV acquisition in women.

Polis CB, Curtis KM, Hannaford PC, Phillips SJ, Chipato T, Kiarie JN, Westreich DJ, Steyn PS.

AIDS. 2016 Nov 13;30(17):2665-2683. Review.

33.

Nonoral combined hormonal contraceptives and thromboembolism: a systematic review.

Tepper NK, Dragoman MV, Gaffield ME, Curtis KM.

Contraception. 2017 Feb;95(2):130-139. doi: 10.1016/j.contraception.2016.10.005. Epub 2016 Oct 19. Review.

PMID:
27771476
34.

Removing medical barriers to contraception - evidence-based recommendations from the Centers for Disease Control and Prevention, 2016.

Curtis KM, Tepper NK, Jatlaoui TC, Whiteman MK.

Contraception. 2016 Dec;94(6):579-581. doi: 10.1016/j.contraception.2016.08.007. Epub 2016 Aug 30. No abstract available.

PMID:
27589882
35.

Research gaps from evidence-based contraception guidance: the US Medical Eligibility Criteria for Contraceptive Use, 2016, and the US Selected Practice Recommendations for Contraceptive Use, 2016.

Horton LG, Folger SG, Berry-Bibee E, Jatlaoui TC, Tepper NK, Curtis KM.

Contraception. 2016 Dec;94(6):582-589. doi: 10.1016/j.contraception.2016.07.017. Epub 2016 Jul 25. No abstract available.

PMID:
27471028
36.

U.S. Selected Practice Recommendations for Contraceptive Use, 2016.

Curtis KM, Jatlaoui TC, Tepper NK, Zapata LB, Horton LG, Jamieson DJ, Whiteman MK.

MMWR Recomm Rep. 2016 Jul 29;65(4):1-66. doi: 10.15585/mmwr.rr6504a1.

PMID:
27467319
37.

U.S. Medical Eligibility Criteria for Contraceptive Use, 2016.

Curtis KM, Tepper NK, Jatlaoui TC, Berry-Bibee E, Horton LG, Zapata LB, Simmons KB, Pagano HP, Jamieson DJ, Whiteman MK.

MMWR Recomm Rep. 2016 Jul 29;65(3):1-103. doi: 10.15585/mmwr.rr6503a1.

PMID:
27467196
38.

Contraceptive use among women with multiple sclerosis: a systematic review.

Zapata LB, Oduyebo T, Whiteman MK, Houtchens MK, Marchbanks PA, Curtis KM.

Contraception. 2016 Dec;94(6):612-620. doi: 10.1016/j.contraception.2016.07.013. Epub 2016 Jul 21. Review.

39.

Drug interactions between hormonal contraceptives and psychotropic drugs: a systematic review.

Berry-Bibee EN, Kim MJ, Simmons KB, Tepper NK, Riley HE, Pagano HP, Curtis KM.

Contraception. 2016 Dec;94(6):650-667. doi: 10.1016/j.contraception.2016.07.011. Epub 2016 Jul 18. Review.

PMID:
27444984
40.

Co-administration of St. John's wort and hormonal contraceptives: a systematic review.

Berry-Bibee EN, Kim MJ, Tepper NK, Riley HE, Curtis KM.

Contraception. 2016 Dec;94(6):668-677. doi: 10.1016/j.contraception.2016.07.010. Epub 2016 Jul 18. Review.

PMID:
27444983
41.

The safety of intrauterine devices in breastfeeding women: a systematic review.

Berry-Bibee EN, Tepper NK, Jatlaoui TC, Whiteman MK, Jamieson DJ, Curtis KM.

Contraception. 2016 Dec;94(6):725-738. doi: 10.1016/j.contraception.2016.07.006. Epub 2016 Jul 13. Review.

PMID:
27421765
42.

Medications to ease intrauterine device insertion: a systematic review.

Zapata LB, Jatlaoui TC, Marchbanks PA, Curtis KM.

Contraception. 2016 Dec;94(6):739-759. doi: 10.1016/j.contraception.2016.06.014. Epub 2016 Jun 29. Review.

43.

Safety of hormonal contraception and intrauterine devices among women with depressive and bipolar disorders: a systematic review.

Pagano HP, Zapata LB, Berry-Bibee EN, Nanda K, Curtis KM.

Contraception. 2016 Dec;94(6):641-649. doi: 10.1016/j.contraception.2016.06.012. Epub 2016 Jun 27. Review.

PMID:
27364100
44.

Safety of intrauterine devices among women with HIV: a systematic review.

Tepper NK, Curtis KM, Nanda K, Jamieson DJ.

Contraception. 2016 Dec;94(6):713-724. doi: 10.1016/j.contraception.2016.06.011. Epub 2016 Jun 22. Review.

PMID:
27343750
45.

Contraceptive safety among women with cystic fibrosis: a systematic review.

Whiteman MK, Oduyebo T, Zapata LB, Walker S, Curtis KM.

Contraception. 2016 Dec;94(6):621-629. doi: 10.1016/j.contraception.2016.05.016. Epub 2016 Jun 7. Review.

PMID:
27287694
46.

The safety of intrauterine contraception initiation among women with current asymptomatic cervical infections or at increased risk of sexually transmitted infections.

Jatlaoui TC, Simmons KB, Curtis KM.

Contraception. 2016 Dec;94(6):701-712. doi: 10.1016/j.contraception.2016.05.013. Epub 2016 Jun 1. Review.

47.

Combined hormonal contraceptive use among obese women and risk for cardiovascular events: A systematic review.

Horton LG, Simmons KB, Curtis KM.

Contraception. 2016 Dec;94(6):590-604. doi: 10.1016/j.contraception.2016.05.014. Epub 2016 Jun 1. Review.

PMID:
27263039
48.

Safety and effectiveness data for emergency contraceptive pills among women with obesity: a systematic review.

Jatlaoui TC, Curtis KM.

Contraception. 2016 Dec;94(6):605-611. doi: 10.1016/j.contraception.2016.05.002. Epub 2016 May 24. Review.

49.

The safety of Sino-implant (II) for women with medical conditions or other characteristics: a systematic review.

Phillips SJ, Steyn PS, Curtis KM.

Contraception. 2016 Sep;94(3):216-25. doi: 10.1016/j.contraception.2016.05.004. Epub 2016 May 20. Review.

50.

Safety of hormonal contraceptives among women with migraine: A systematic review.

Tepper NK, Whiteman MK, Zapata LB, Marchbanks PA, Curtis KM.

Contraception. 2016 Dec;94(6):630-640. doi: 10.1016/j.contraception.2016.04.016. Epub 2016 May 3. Review.

PMID:
27153744

Supplemental Content

Loading ...
Support Center